Edding Genor Group Holdings Ltd
06998
Company Profile
Business description
Edding Genor Group Holdings Ltd is a biopharmaceutical company with the vision of China. Its majority therapeutic areas include oncology, autoimmune, cardiovascular, respiratory and anti-infectives. Its drugs includes Vascepa, Mulpleta, Jingzhuda, and Rujianing.
Contact
248 Queen’s Road East
40th Floor, Dah Sing Financial Centre
Wanchai
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
1,545
Stocks News & Analysis
stocks
US utilities stocks keep rallying as investors bet on power demand growth
Rising electricity demand from data centers supports earnings growth, but Morningstar analysts say the sector looks less attractive after a sharp rally.
stocks
What did Morningstar subscribers buy and sell during March?
How the most traded shares in March stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,174.40 | 32.00 | -0.35% |
| CAC 40 | 8,235.98 | 23.62 | -0.29% |
| DAX 40 | 23,742.44 | 61.51 | -0.26% |
| Dow JONES (US) | 48,218.25 | 301.68 | 0.63% |
| FTSE 100 | 10,582.96 | 17.57 | -0.17% |
| HKSE | 25,743.40 | 82.55 | 0.32% |
| NASDAQ | 23,183.74 | 280.84 | 1.23% |
| Nikkei 225 | 57,821.70 | 1,318.93 | 2.33% |
| NZX 50 Index | 13,017.26 | 2.92 | -0.02% |
| S&P 500 | 6,886.24 | 69.35 | 1.02% |
| S&P/ASX 200 | 8,980.20 | 33.80 | -0.37% |
| SSE Composite Index | 4,006.53 | 17.97 | 0.45% |